tm logo

Monitor this mark

View On USPTO

APTENSIO XR
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 04 Nov 2021

Last Applicant/ Owned by

RHODES PHARMACEUTICALS L.P.

498 WASHINGTON STREET

COVENTRY

RI

02816

Serial Number

85838161 filed on 01st Feb 2013

Registration Number

4822493 registered on 29th Sep 2015

in the Principal Register

Correspondent Address

Fara S. Sunderji

Fara S. Sunderji Dorsey & Whitney LLP

51 West 52nd Street, NY 10019-6119

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

APTENSIO XR

Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)

First Use Date in General

31st Jul 2015

First Use Date in Commerce

31st Jul 2015

Mark Details

Serial Number

No 85838161

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 509141-00001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
29th Sep 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04th Nov 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04th Nov 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04th Nov 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30th Jul 2021TEAS SECTION 8 & 15 RECEIVED
29th Sep 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
29th Jul 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
15th May 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15th May 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29th Sep 2015REGISTERED-PRINCIPAL REGISTER